Medical Director, Oncology Clinical Development

Benefits

Qualifications

• •Basic Qualifications Medical degree with board certification or eligibility in medical oncology, hematology, hematology/oncology, general surgery, internal medicine, or pathology
• •Oncology experience in the pharmaceutical/biotechnology industry, clinical academic medicine, or clinical practice settings
• •Experience conducting or participating in clinical trials and related publications
• •PhD degree with board or registration certification
• •Experience in lung or head & neck oncology clinical trials, including study design, data review and interpretation
• •Knowledge of regulatory requirements to support registration, including GCP principles
• •Robust knowledge of disease‑specific research priorities, public health needs, competitor landscape, clinical practice trends and treatment‑guideline evolution
• •4 more items(s)

Responsibilities

• •The Medical Director, Oncology Clinical Development will report to the Executive Medical Director, Clinical Development Lead (CDL)
• •This physician‑level position is responsible for advancing the development of GSK’s oncology portfolio through clinical research activities and leading medical dialogues with scientific and medical leaders
• •The role requires engaging in the design and execution of phase 1‑3 interventional clinical trials, ensuring scientific integrity, and building relationships with key external experts
• •The position requires an on‑site office‑based presence two to three days a week in one of the following locations: UK (London or Stevenage), Switzerland (Zug), US (Upper Providence, PA or Waltham, MA), or Poland (Warsaw)
• •Key Responsibilities Collaborate with medical directors, scientists, regulators, biostatisticians and executive staff to develop and execute phase 1‑3 interventional clinical trials
• •Ensure high‑quality protocol development aligned with the Clinical Development Plan to determine a medicine’s efficacy, safety, differentiation and patient value in a timely manner
• •Use medical expertise to oversee the end‑to‑end trial process, ensuring scientific integrity and alignment with regulatory approvals and market launch strategy
• •Interpret and summarize study results to define safety, efficacy, PK/PD, and patient‑reported outcomes for the target population
• •Assume medical responsibility for clinical trials, including real‑time monitoring of studies, patient eligibility assessment, study design questions and urgent safety aspects
• •Lead medical review of clinical trial data, oversee delegated reviews, and conduct blinded reviews for IDMCs
• •Collaborate with pharmacovigilance to review safety data for active studies
• •Participate in authoring clinical study reports and regulatory documents and respond to health authority and ethics‑committee queries
• •Collaborate with principal investigators to evaluate publications related to clinical data
• •Network extensively to develop long‑term strategic partnerships with internal and external thought leaders. Understand disease mechanisms, clinical strategy and scientific interpretation of disease and target‑based literature
• •Serve as a core member of the Clinical Matrix Team for assigned assets and represent Clinical Development on disease‑area strategy and integrated evidence teams
• •Participate in Oncology Clinical Development‑wide initiatives and workstreams as appropriate
• •13 more items(s)